{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:04:54Z","timestamp":1765807494082},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471327"],"award-info":[{"award-number":["81471327"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding","doi-asserted-by":"crossref","award":["XMLX201304","ZYLX201305"],"award-info":[{"award-number":["XMLX201304","ZYLX201305"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Capital Characteristic Clinic Project","award":["Z131107002213065"],"award-info":[{"award-number":["Z131107002213065"]}]}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.yebeh.2017.08.011","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T06:18:04Z","timestamp":1508221084000},"page":"90-95","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis"],"prefix":"10.1016","volume":"77","author":[{"given":"Chao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Xiong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Zhi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Tao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Qiu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2017.08.011_bb0005","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0010","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0015","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","article-title":"Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels","volume":"124","author":"Liguori","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp-2016-314758","article-title":"Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies","volume":"88","author":"Lang","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0025","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0030","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede LGI1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0035","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1684\/j.1950-6945.2005.tb00123.x","article-title":"Pilomotor seizures and status in non-paraneoplastic limbic encephalitis","volume":"7","author":"Wieser","year":"2005","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0050","first-page":"751510","article-title":"Temporal lobe epilepsy semiology","volume":"2012","author":"Blair","year":"2012","journal-title":"Epilepsy Res Treat"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.spen.2014.08.002","article-title":"Focal epilepsies: immunologic and inflammatory mechanisms","volume":"21","author":"Khurana","year":"2014","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0060","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1073\/pnas.0914537107","article-title":"Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy","volume":"107","author":"Fukata","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0065","doi-asserted-by":"crossref","DOI":"10.3171\/2012.1.FOCUS11334","article-title":"Brain stimulation for the treatment of epilepsy","volume":"32","author":"Fridley","year":"2012","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0070","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/brain\/awx070","article-title":"Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis","volume":"140","author":"Miller","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2009.10.013","article-title":"Regional distribution of the leucine-rich glioma inactivated (LGI) gene family transcripts in the adult mouse brain","volume":"1307","author":"Herranz-Perez","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0080","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/brain\/aww012","article-title":"Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis","volume":"139","author":"Navarro","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0085","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0090","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/brain\/awv134","article-title":"Parallel basal ganglia circuits for voluntary and automatic behaviour to reach rewards","volume":"138","author":"Kim","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ana.22470","article-title":"Faciobrachial dystonic attacks: seizures or movement disorder?","volume":"70","author":"Striano","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0100","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s00415-013-6946-7","article-title":"Faciobrachial dystonic seizures arise from cortico-subcortical abnormal brain areas","volume":"260","author":"Boesebeck","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0105","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1212\/WNL.0b013e3182152808","article-title":"Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?","volume":"76","author":"Andrade","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1528-1167.2009.02287.x","article-title":"Adult-onset drug-refractory seizure disorder associated with anti-voltage-gated potassium-channel antibody","volume":"51","author":"Barajas","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0115","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1212\/01.wnl.0000326572.93762.51","article-title":"Immunotherapy-responsive seizure-like episodes with potassium channel antibodies","volume":"71","author":"Irani","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0120","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000161","article-title":"Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures","volume":"2","author":"Flanagan","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3174\/ajnr.A3633","article-title":"MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis","volume":"35","author":"Kotsenas","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12883-014-0194-z","article-title":"Temporal lobe epilepsy with amygdala enlargement: a subtype of temporal lobe epilepsy","volume":"14","author":"Lv","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0135","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jnnp.2010.206342","article-title":"Amygdalar enlargement in patients with temporal lobe epilepsy","volume":"82","author":"Mitsueda-Ono","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2017.08.011_bb0140","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/jcbfm.2013.160","article-title":"Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier","volume":"33","author":"St-Amour","year":"2013","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017303074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017303074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T20:41:30Z","timestamp":1719520890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505017303074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":28,"alternative-id":["S1525505017303074"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.08.011","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}